SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-046313
Filing Date
2024-05-23
Accepted
2024-05-23 17:00:15
Documents
15
Period of Report
2024-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206715-8k_abvcbio.htm   iXBRL 8-K 32950
2 LETTER AGREEMENT ea020671501ex10-1_abvcbio.htm EX-10.1 53160
3 FORM OF WARRANT ea020671501ex10-2_abvcbio.htm EX-10.2 91066
  Complete submission text file 0001213900-24-046313.txt   390921

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abvc-20240522.xsd EX-101.SCH 3021
5 XBRL LABEL FILE abvc-20240522_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE abvc-20240522_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0206715-8k_abvcbio_htm.xml XML 3568
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 24979388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)